Sanofi: Dupixent recommended for EU approval by the CHMP to

Dupixent recommended for EU approval by the CHMP to treat patients with COPD Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3

Related Keywords

Paris , France General , France , Massachusetts , United States , China , Corentine Driancourt , Timothy Gilbert , Sandrine Guendoul , Vesna Tosic , Felix Lauscher , Nathalie Pham , Tarik Elgoutni , Evan Berland , Hannah Kwagh , Thomas Kudsk Larsen , European Commission Of Dupixent , Regeneron Genetics Center , European Commission , Clinical Research Program , Nasdaq , Us Department Of Justice , Facebook , Euronext , Dupilumab Development Program , Linkedin , European Union , Drug Administration , Instagram , Regeneron Pharmaceuticals Inc , Exchange Commission , European Medicines Agency , Medicinal Products , Human Use , Respiratory Questionnaire , Priority Review , Biologics License Application , Regeneron Genetics , Kudsk Larsen , Private Securities Litigation Reform Act , Statement Regarding Forward Looking , Forward Looking Statements , Digital Media , Regeneron Pharmaceuticals , Product Candidates , Ihr Portfolio ,